AES ACCELERATED ENROLLMENT SOLUTIONS

Serial Number 90815668
Registration 6807074
700

Registration Progress

Application Filed
Jul 7, 2021
Under Examination
Approved for Publication
May 17, 2022
Published for Opposition
May 17, 2022
Registered
Aug 2, 2022

Trademark Image

AES ACCELERATED ENROLLMENT SOLUTIONS

Basic Information

Serial Number
90815668
Registration Number
6807074
Filing Date
July 7, 2021
Registration Date
August 2, 2022
Published for Opposition
May 17, 2022
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
Aug 2, 2022
Registration
Registered
Classes
035 042

Rights Holder

Synexus Clinical Research US, Inc.

03
Address
2005 S Easton Road 
Suite 304
Doylestown, PA 18901

Ownership History

Synexus Clinical Research US, Inc.

Original Applicant
03
Horsham, PA

Synexus Clinical Research US, Inc.

Owner at Publication
03
Horsham, PA

Synexus Clinical Research US, Inc.

Original Registrant
03
Doylestown, PA

Legal Representation

Attorney
Kenya L. Williams

USPTO Deadlines

Next Deadline
1119 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-08-02)
Due Date
August 02, 2028
Grace Period Ends
February 02, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

24 events
Date Code Type Description
Aug 18, 2022 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 18, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 18, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 18, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 18, 2022 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 2, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER
Aug 2, 2022 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 17, 2022 PUBO A PUBLISHED FOR OPPOSITION
May 17, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 27, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 14, 2022 CNEA R EXAMINERS AMENDMENT -WRITTEN
Apr 14, 2022 GNEA O EXAMINERS AMENDMENT E-MAILED
Apr 14, 2022 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 14, 2022 XAEC I EXAMINER'S AMENDMENT ENTERED
Apr 14, 2022 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 4, 2022 CNRT R NON-FINAL ACTION WRITTEN
Apr 4, 2022 GNRT F NON-FINAL ACTION E-MAILED
Apr 4, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 25, 2022 DOCK D ASSIGNED TO EXAMINER
Nov 23, 2021 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 23, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 23, 2021 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 15, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 10, 2021 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 035
Business management of clinical trials for others; recruitment of clinical drug trial participants, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs; marketing of healthcare and pharmaceutical products of others; compiling information into computer databases, namely, collecting and compiling consumer preference information regarding health conditions, clinical trial participation interest, and clinical trial candidacy for business purposes; collection of market research information, namely, collecting and compiling clinical trial statistics and information for business purposes
First Use Anywhere: May 1, 2019
First Use in Commerce: May 1, 2019
Class 042
Clinical research and scientific analysis in the field of pharmaceutical drugs, medical devices, and clinical trials
First Use Anywhere: May 1, 2019
First Use in Commerce: May 1, 2019

Classification

International Classes
035 042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"ACCELERATED ENROLLMENT SOLUTIONS"